This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
|Zacks Rank||Definition||Annualized Return|
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at firstname.lastname@example.org or call 800-767-3771 ext. 9339.
• Shares of Dreams Inc. (NYSEAMEX: DRJ) rose 30.3% after the retailer agreed to be purchased by privately owned online sports merchandiser Fanatics Inc. for $3.45 a share
• Shares of Endocyte Inc. (NASDAQ:ECYT) jumped 100.5% after Merck & Co. (NYSE:MRK) struck a deal worth up to $1 billion to develop an experimental cancer drug and announced that it would pay $120 million upfront to Endocyte with additional payouts of up to $880 million
• Mattel Inc. (NASDAQ:MAT) lost 9.1% after reporting first quarter earnings per share of $0.06, missing the Zacks Consensus Estimate of $0.07 by a penny
• Gannett Co. (NYSE:GCI) fell 7.6% a day after the media firm released its earnings, even though quarterly earnings per share of $0.34 surpassed the Zacks Consensus Estimate of $0.31
Please login to Zacks.com or register to post a comment.